Navigation Links
Shire to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
Date:6/11/2013

LEXINGTON, Massachusetts, June 11, 2013 /PRNewswire/ --


Shire's Chief Financial Officer, Graham Hetherington will present at the Goldman Sachs 34th Annual Global Healthcare Conference on Wednesday, June 12th at 9:20 AM PT /17:20 BST. Investors may access a live audio webcast of the presentation at http://www.shire.com/shireplc/en/investors.

NOTES TO EDITORS

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.

http://www.shire.com

For further information please contact:

Investor Relations:

Souheil Salah, ssalah@shire.com, +44-1256-894160

Erin K. Kelly, erikelly@shire.com, +1-781-482-9541


'/>"/>
SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Shire Launches Report that Quantifies the Health, Psycho-social and Economic Impact of Rare Diseases
2. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
3. Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
4. Shire Reaches Agreement in Principle With U.S. Government
5. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
6. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
7. Shire Changes its NASDAQ Ticker Symbol to SHPG
8. Berkshire Corporation Offers Live Chat For Americas Website and Shopping Cart
9. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
10. Shire plc: First Quarter 2012 Results Date Notification - April 26, 2012
11. Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... ... AMRI, a global contract research, development and manufacturing organization ... quality of life, will now be offering its impurity solutions as a stand-alone ... for all new drug products, including the finalization of ICH M7 earlier this ...
(Date:10/11/2017)... ... 11, 2017 , ... Personal eye wash is a basic first aid supply for any work ... which eye do you rinse first if a dangerous substance enters both eyes? It’s one ... with its unique dual eye piece. , “Whether its dirt and debris, or an ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/10/2017)... ... , ... San Diego-based team building and cooking events company, Lajollacooks4u, has unveiled ... bold new look is part of a transformation to increase awareness, appeal to new ... , It will also expand its service offering from its signature gourmet cooking classes ...
Breaking Biology Technology:
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced ... will feature emerging and evolving technology through ... Innovation Summits will run alongside the expo portion of ... sessions, panels and demonstrations focused on trending topics within ... advanced design and manufacturing event will take place June ...
(Date:4/11/2017)... , April 11, 2017 No two ... researchers at the New York University Tandon School ... Engineering have found that partial similarities between prints ... used in mobile phones and other electronic devices ... The vulnerability lies in the fact that ...
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
Breaking Biology News(10 mins):